• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犰狳来源的麻风分枝杆菌制备疫苗的分析;世界卫生组织协调的一项实验室间研究结果。世界卫生组织分枝杆菌病免疫学(IMMYC)指导委员会

Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization.

出版信息

Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):48-55.

PMID:7730719
Abstract

Preparations of armadillo-derived Mycobacterium leprae used in vaccine trials were analyzed using a combination of morphological, chemical and immunological criteria. When compared to more recent preparations, vaccine lots prepared in 1984 and 1985 were found to contain fewer intact bacilli and lower amounts of M. leprae antigens. These differences may be characteristic of the original preparations, or alternatively, may have arisen during prolonged storage. The early vaccine lots were those used in the recently published Venezuela trial.

摘要

使用形态学、化学和免疫学标准相结合的方法,对用于疫苗试验的犰狳源麻风分枝杆菌制剂进行了分析。与最近的制剂相比,发现1984年和1985年制备的疫苗批次中完整杆菌数量较少,麻风分枝杆菌抗原含量较低。这些差异可能是原始制剂的特征,也可能是在长期储存过程中产生的。早期的疫苗批次是最近发表的委内瑞拉试验中使用的批次。

相似文献

1
Analysis of vaccines prepared from armadillo-derived M. leprae; results of an inter-laboratory study coordinated by the World Health Organization. Immunology of Mycobacterial Diseases (IMMYC) Steering Committee, World Health Organization.犰狳来源的麻风分枝杆菌制备疫苗的分析;世界卫生组织协调的一项实验室间研究结果。世界卫生组织分枝杆菌病免疫学(IMMYC)指导委员会
Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):48-55.
2
Regarding analysis of vaccines.关于疫苗分析。
Int J Lepr Other Mycobact Dis. 1995 Dec;63(4):576-7.
3
Differential handling of bacterial antigens in macrophages infected with Mycobacterium leprae as studied by immunogold labeling of ultrathin sections.通过超薄切片免疫金标记研究麻风分枝杆菌感染巨噬细胞中细菌抗原的差异处理
Int J Lepr Other Mycobact Dis. 1991 Jun;59(2):278-91.
4
Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.从犰狳源麻风分枝杆菌制备抗麻风病疫苗的进展。
Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):515-8.
5
Lymphocyte response of leprosy patients to human-derived and purified armadillo-derived Mycobacterium leprae, BCG and PPD.麻风病患者对人源及纯化犰狳源麻风分枝杆菌、卡介苗和结核菌素纯蛋白衍生物的淋巴细胞反应。
Clin Exp Immunol. 1978 Nov;34(2):164-9.
6
Animal vaccination studies with Mycobacterium leprae.
Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):519-23.
7
Research in leprosy. A report of a committee set up by the medical research council to study future prospects.麻风病研究。医学研究理事会设立的一个委员会关于研究未来前景的报告。
Clin Exp Immunol. 1979 Apr;36(1):1-7.
8
General ideas concerning a vaccine against leprosy: a basis for discussion during the Eleventh International Leprosy Congress.关于麻风病疫苗的总体构想:第十一届国际麻风病大会期间的讨论基础
Int J Lepr Other Mycobact Dis. 1978 Jan-Mar;46(1):61-3.
9
Rationales for vaccines against leprosy.
Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):505-9.
10
Leprosy vaccine: India finally agrees to trials.麻风病疫苗:印度最终同意进行试验。
Nature. 1989 Aug 10;340(6233):417. doi: 10.1038/340417a0.